WASHINGTON -- A small implant delivering electrical stimulation to the vagus nerve outperformed a sham treatment in relieving ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...

Mass Eye and Ear researchers have led a clinical trial of a drug that mimics the effects of alcohol in more than 100 patients ...

KarXT - Nicola Rizzo Pesci and Andrea Cipriani summarise findings from the EMERGENT-2 trial spotlighting a promising new ...

The GLP-1 receptor agonist improved both histology and fibrosis in patients, with additional improvements in their liver ...

The brief requests the dismissal of FTC’s complaint against Xlear based on the Supreme Court’s recent decision in Loper ...

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Psilocybin effects on depression and anxiety are generally safe and well-tolerated, but researchers should focus on determining optimal dosage.

A randomized controlled trial involving more than 3,600 patients hospitalized with bloodstream infections found that 7 days ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

Echocardiography that uses artificial intelligence reduces observer variability and produces better quality images, a randomized controlled trial shows.